NF-kB p65 expression is a favorable prognostic factor in high-grade serous ovarian carcinoma

被引：0
|
作者：
Liu, J. [1 ]
Rosen, D. G. [1 ]
机构：
[1] MD Anderson Canc Ctr, Houston, TX USA
来源：
MODERN PATHOLOGY | 2007年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
942
引用
收藏
页码：206A / 206A
页数：1
相关论文
共 50 条
  • [41] Hormonal receptor expression and clinical outcome in ovarian high-grade serous carcinoma
    George, S.
    Sowamber, R.
    Dodds, L.
    Jordan, S. E.
    Paudel, I.
    Huang, M.
    Pinto, A.
    Schlumbrecht, M. P.
    Shaw, P.
    Slomovitz, B. M.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 73 - 73
  • [42] ADAM12 is a prognostic factor associated with an aggressive molecular subtype of high-grade serous ovarian carcinoma
    Cheon, Dong-Joo
    Li, Andrew J.
    Beach, Jessica A.
    Walts, Ann E.
    Tran, Hang
    Lester, Jenny
    Karlan, Beth Y.
    Orsulic, Sandra
    CARCINOGENESIS, 2015, 36 (07) : 739 - 747
  • [43] Differential expression of immune related genes in high-grade ovarian serous carcinoma
    Siamakpour-Reihani, Sharareh
    Cobb, Lauren Patterson
    Jiang, Chen
    Zhang, Dadong
    Previs, Rebecca A.
    Owzar, Kouros
    Nixon, Andrew B.
    Secord, Angeles Alvarez
    GYNECOLOGIC ONCOLOGY, 2020, 156 (03) : 662 - 668
  • [44] Modulation of inflammatory gene expression by interaction of p65 NF-kB and cyclin-dependent kinase 6
    Beuerlein, K.
    Mueller, H.
    Weber, A.
    Handschick, K.
    Dittrich-Breiholz, O.
    Schneider, H.
    Schmitz, L.
    Kracht, M.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2011, 383 : 64 - 64
  • [45] High-grade ovarian serous carcinoma exhibits significantly higher p16 expression than low-grade serous carcinoma and serous borderline tumour
    O'Neill, C. J.
    McBride, H. A.
    Connolly, L. E.
    Deavers, M. T.
    Malpica, A.
    McCluggage, W. G.
    HISTOPATHOLOGY, 2007, 50 (06) : 773 - 779
  • [46] Prognostic value of ALK overexpression and molecular abnormalities in high-grade serous ovarian carcinoma
    Gorczynski, Adam
    Miszewski, Kevin
    Gager, Yann
    Koch, Sonja
    Poetschke, Jane
    Ugrinovski, Dimitar
    Gabert, Joerg
    Pospieszynska, Agata
    Wydra, Dariusz
    Duchnowska, Renata
    Szymanowski, Bartosz
    Cierniak, Szczepan
    Kruecken, Irene
    Neumann, Karsten
    Mirkov, Katarina
    Biernat, Wojciech
    Czapiewski, Piotr
    CANCER BIOMARKERS, 2023, 38 (01) : 17 - 26
  • [47] Cleaved caspase-3 and nuclear factor-κB p65 are prognostic factors in metastatic serous ovarian carcinoma
    Kleinberg, Lilach
    Dong, Hiep Phuc
    Holth, Arild
    Risberg, Bjoern
    Trope, Claes G.
    Nesland, Jahn M.
    Florenes, Vivi Ann
    Davidson, Ben
    HUMAN PATHOLOGY, 2009, 40 (06) : 795 - 806
  • [48] Extracellular microRNA profiling for prognostic prediction in patients with high-grade serous ovarian carcinoma
    Yoshida, Kosuke
    Yokoi, Akira
    Matsuzaki, Juntaro
    Kato, Tomoyasu
    Ochiya, Takahiro
    Kajiyama, Hiroaki
    Yamamoto, Yusuke
    CANCER SCIENCE, 2021, 112 (12) : 4977 - 4986
  • [49] Prognostic impact of HER3 based on protein and mRNA expression in high-grade serous ovarian carcinoma
    Ulrike Unger
    Carsten Denkert
    Ioana Braicu
    Jalid Sehouli
    Manfred Dietel
    Sibylle Loibl
    Silvia Darb-Esfahani
    Virchows Archiv, 2017, 470 : 143 - 151
  • [50] Prognostic value of progesterone receptor expression in tubo-ovarian high-grade serous carcinoma of the COEUR cohort
    Le Page, Cecile
    Rahimi, Kurosh
    Mes-Masson, Anne-Marie
    Kobel, Martin
    HISTOPATHOLOGY, 2019, 74 (04) : 663 - 666
12345